Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 413

1.

Editors' note: Safety and efficacy of venoplasty in MS: A randomized, double-blind, sham-controlled phase II trial.

Ganesh A, Galetta S.

Neurology. 2019 Aug 13;93(7):319. doi: 10.1212/WNL.0000000000007953. No abstract available.

PMID:
31405938
2.

Editors' note: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Aug 6;93(6):278. doi: 10.1212/WNL.0000000000007911. No abstract available.

PMID:
31383806
3.

Editors' note: Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Aug 6;93(6):277. doi: 10.1212/WNL.0000000000007903. No abstract available.

PMID:
31383803
4.

Editors' note: Residency Training: Enhancing resiliency in our residents: Combining the principles of business and neurobiology.

Lewis A, Galetta S.

Neurology. 2019 Jul 30;93(5):228. doi: 10.1212/WNL.0000000000007877. No abstract available.

PMID:
31358674
5.

Editors' note: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.

Lewis A, Galetta S.

Neurology. 2019 Jul 30;93(5):228. doi: 10.1212/WNL.0000000000007868. No abstract available.

PMID:
31358672
6.

Editors' note: Pearls & Oy-sters: Pembrolizumab-induced myasthenia gravis.

Ganesh A, Galetta S.

Neurology. 2019 Jul 23;93(4):182-183. doi: 10.1212/WNL.0000000000007844. No abstract available.

PMID:
31332090
7.

Editors' note: BOLD cerebrovascular reactivity as a novel marker for crossed cerebellar diaschisis.

Ganesh A, Galetta S.

Neurology. 2019 Jul 23;93(4):181. doi: 10.1212/WNL.0000000000007842. No abstract available.

PMID:
31332087
8.

Eye position-dependent opsoclonus in mild traumatic brain injury.

Rizzo JR, Hudson TE, Sequeira AJ, Dai W, Chaudhry Y, Martone J, Zee DS, Optican LM, Balcer LJ, Galetta SL, Rucker JC.

Prog Brain Res. 2019;249:65-78. doi: 10.1016/bs.pbr.2019.04.016. Epub 2019 May 23.

PMID:
31325998
9.

Editors' note: A sleep medicine medical school curriculum: Time for us to wake up.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Jul 16;93(3):133. doi: 10.1212/WNL.0000000000007791. No abstract available.

PMID:
31308166
10.

Editors' note: Incorporating sleep medicine content into medical school through neuroscience core curricula.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Jul 16;93(3):132. doi: 10.1212/WNL.0000000000007789. No abstract available.

PMID:
31308163
11.

Editors' note: To harvest?: A reality-based ethical dilemma and fictional dialogue.

Lewis A, Galetta S.

Neurology. 2019 Jul 9;93(2):86-87. doi: 10.1212/WNL.0000000000007763. No abstract available.

PMID:
31285406
12.

Editors' note: ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.

Lewis A, Galetta S.

Neurology. 2019 Jul 9;93(2):85. doi: 10.1212/WNL.0000000000007759. No abstract available.

PMID:
31285403
13.

Editors' note: Idiopathic intracranial hypertension: The veno glymphatic connections.

Ganesh A, Galetta S.

Neurology. 2019 Jul 2;93(1):42. doi: 10.1212/WNL.0000000000007734. No abstract available.

PMID:
31262989
14.

Editors' note: Clinical Reasoning: A 54-year-old woman with confusion and visual disturbances.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Jun 11;92(24):1165. doi: 10.1212/WNL.0000000000007671. No abstract available.

PMID:
31182517
16.

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.

Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.

BMC Neurol. 2019 Jun 8;19(1):116. doi: 10.1186/s12883-019-1337-z.

17.

Editors' note: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial.

Lewis A, Galetta S.

Neurology. 2019 Jun 4;92(23):1121. doi: 10.1212/WNL.0000000000007624. No abstract available.

PMID:
31160409
18.

Editors' note: Severe hyperhomocysteinemia manifesting as moyamoya vasculopathy and Henoch-Schonlein purpura.

Lewis A, Galetta S.

Neurology. 2019 Jun 4;92(23):1119. doi: 10.1212/WNL.0000000000007620. No abstract available.

PMID:
31160406
19.

Clinical Reasoning: A 55-year-old obese woman with headache and rhinorrhea.

Conway J, Grossman S, Varnado S, Frucht S, Balcer L, Minen M, Galetta S.

Neurology. 2019 May 28;92(22):e2614-e2617. doi: 10.1212/WNL.0000000000007582. No abstract available.

PMID:
31133569
20.

Editors' note: Urinary cadmium concentration and the risk of ischemic stroke.

Ganesh A, Galetta S.

Neurology. 2019 May 28;92(22):1071. doi: 10.1212/WNL.0000000000007589. No abstract available.

PMID:
31133566
21.

Editors' note: Alien hand syndrome.

Ganesh A, Galetta S.

Neurology. 2019 May 28;92(22):1070. doi: 10.1212/WNL.0000000000007584. No abstract available.

PMID:
31133564
22.

Editors' note: Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: A case-control study.

Siegler JE 3rd, Galetta S.

Neurology. 2019 May 21;92(21):1024. doi: 10.1212/WNL.0000000000007547. No abstract available.

PMID:
31110147
23.

MULES on the sidelines: A vision-based assessment tool for sports-related concussion.

Fallon S, Akhand O, Hernandez C, Galetta MS, Hasanaj L, Martone J, Webb N, Drattell J, Amorapanth P, Rizzo JR, Nolan-Kenney R, Serrano L, Rucker JC, Cardone D, Galetta SL, Balcer LJ.

J Neurol Sci. 2019 Jul 15;402:52-56. doi: 10.1016/j.jns.2019.04.036. Epub 2019 Apr 28.

PMID:
31103959
24.

Editors' note: DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial.

Lewis A, Galetta S.

Neurology. 2019 May 14;92(20):974. doi: 10.1212/WNL.0000000000007520. No abstract available.

PMID:
31085729
25.

Editors' note: Ethical, palliative, and policy considerations in disorders of consciousness.

Lewis A, Galetta S.

Neurology. 2019 May 14;92(20):973. doi: 10.1212/WNL.0000000000007513. No abstract available.

PMID:
31085726
26.

Editors' note: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.

Ganesh A, Galetta S.

Neurology. 2019 May 7;92(19):924. doi: 10.1212/WNL.0000000000007457. No abstract available.

PMID:
31061215
27.

Editors' note: Women physicians underrepresented in American Academy of Neurology recognition awards.

Ganesh A, Galetta S.

Neurology. 2019 May 7;92(19):923. doi: 10.1212/WNL.0000000000007461. No abstract available.

PMID:
31061212
28.

Editors' note: Mystery Case: Bilateral temporal crescent sparing after cardiac arrest.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Apr 30;92(18):870. doi: 10.1212/WNL.0000000000007413. No abstract available.

PMID:
31036576
29.

Editors' note: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.

Ganesh A, Galetta S.

Neurology. 2019 Apr 30;92(18):868. doi: 10.1212/WNL.0000000000007410. No abstract available.

PMID:
31036573
30.

Editors' note: Association of statin use with spontaneous intracerebral hemorrhage: A cohort study.

Lewis A, Galetta S.

Neurology. 2019 Apr 23;92(17):821. doi: 10.1212/WNL.0000000000007358. No abstract available.

PMID:
31010912
31.

Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculography.

Villoslada P, Green AJ, Galetta S.

Neurology. 2019 May 14;92(20):929-930. doi: 10.1212/WNL.0000000000007493. Epub 2019 Apr 19. No abstract available.

PMID:
31004068
32.

Editors' note: Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Apr 16;92(16):776. doi: 10.1212/WNL.0000000000007307. No abstract available.

PMID:
30988090
33.

Editors' note: The systolic blood pressure sweet spot after intracerebral hemorrhage: 130 mm Hg?

Ganesh A, Galetta S.

Neurology. 2019 Apr 16;92(16):774. doi: 10.1212/WNL.0000000000007306. No abstract available.

PMID:
30988087
34.

Editors' note: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Apr 9;92(15):731. doi: 10.1212/WNL.0000000000007284. No abstract available.

PMID:
30962303
35.

Editors' note: Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Apr 9;92(15):728. doi: 10.1212/WNL.0000000000007281. No abstract available.

PMID:
30962299
36.

Disputes, debates, dialogue, and dodgers.

Rahkola A, Galetta S.

Neurology. 2019 May 7;92(19):875-876. doi: 10.1212/WNL.0000000000007443. Epub 2019 Apr 3. No abstract available.

PMID:
30944241
37.

Editors' note: The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging.

Lewis A, Galetta S.

Neurology. 2019 Apr 2;92(14):682. doi: 10.1212/WNL.0000000000007225. No abstract available.

PMID:
30936232
38.

Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses.

Nguyen J, Rothman A, Gonzalez N, Avornu A, Ogbuokiri E, Balcer LJ, Galetta SL, Frohman EM, Frohman T, Crainiceanu C, Calabresi PA, Saidha S.

J Neuroophthalmol. 2019 Mar 26. doi: 10.1097/WNO.0000000000000768. [Epub ahead of print]

PMID:
30921169
39.

Teaching NeuroImages: Scleral thickening and optic disc edema from glycosaminoglycan deposition in Hunter syndrome.

Seay MD, Lau H, Galetta SL.

Neurology. 2019 Mar 26;92(13):e1532-e1533. doi: 10.1212/WNL.0000000000007183. No abstract available.

PMID:
30910949
40.

Editors' note: A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

Ganesh A, Galetta S.

Neurology. 2019 Mar 26;92(13):636. doi: 10.1212/WNL.0000000000007170. No abstract available.

PMID:
30910945
41.

Editors' note: Disability in adults with arthrogryposis is severe, partly invisible, and varies by genotype.

Ganesh A, Galetta S.

Neurology. 2019 Mar 26;92(13):635. doi: 10.1212/WNL.0000000000007167. No abstract available.

PMID:
30910942
42.

Editors' note: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Mar 19;92(12):586. doi: 10.1212/WNL.0000000000007130. No abstract available.

PMID:
30886077
43.

Editors' note: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Mar 19;92(12):585. doi: 10.1212/WNL.0000000000007127. No abstract available.

PMID:
30886074
44.

Editors' note: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease.

Lewis A, Galetta S.

Neurology. 2019 Mar 12;92(11):543. doi: 10.1212/WNL.0000000000007086. No abstract available.

PMID:
30858246
45.

Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.

Lewis A, Galetta S.

Neurology. 2019 Mar 12;92(11):542. doi: 10.1212/WNL.0000000000007082. No abstract available.

PMID:
30858243
46.

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Papadopoulou A, Pisa M, Zimmermann H, Galetta SL, Balcer LJ; International Multiple Sclerosis Visual System Consortium.

Ann Neurol. 2019 May;85(5):618-629. doi: 10.1002/ana.25462. Epub 2019 Apr 10.

PMID:
30851125
47.

Editors' note: Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater.

Ganesh A, Galetta S.

Neurology. 2019 Mar 5;92(10):494. doi: 10.1212/WNL.0000000000007027. No abstract available.

PMID:
30833477
48.

Editors' note: Pattern of polyphenol intake and the long-term risk of dementia in older persons.

Ganesh A, Galetta S.

Neurology. 2019 Mar 5;92(10):493. doi: 10.1212/WNL.0000000000007030. No abstract available.

PMID:
30833475
49.

Editors' note: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.

Siegler JE 3rd, Galetta S.

Neurology. 2019 Feb 26;92(9):446. doi: 10.1212/WNL.0000000000006995. No abstract available.

PMID:
30804058
50.

Editors' note: Incidence of MS has increased markedly over 6 decades in Denmark particularly with late onset and in women.

Lewis A, Galetta S.

Neurology. 2019 Feb 19;92(8):396. doi: 10.1212/WNL.0000000000006943. No abstract available.

PMID:
30777916

Supplemental Content

Loading ...
Support Center